Mednax

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages R1 RCM Inc. (RCM) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Friday, December 2, 2022
Steve Berman (lawyer), Bernard Joseph Flanagan, Mednax, News, Fraud, Person, Key Performance Parameters, RCM, SAN, Real estate, Risk management

SAN FRANCISCO, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM) investors who suffered significant losses to submit your losses now .
  • Management revealed that these customers had unique complexities, which resulted in R1 RCM taking longer to achieve its expected performance goals.
  • If you invested in R1 RCM and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages R1 RCM Inc. (RCM) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Thursday, November 17, 2022
Steve Berman (lawyer), Bernard Joseph Flanagan, Person, Mednax, Fraud, RCM, News, Key Performance Parameters, Real estate, Risk management

Management revealed that these customers had unique complexities, which resulted in R1 RCM taking longer to achieve its expected performance goals.

Key Points: 
  • Management revealed that these customers had unique complexities, which resulted in R1 RCM taking longer to achieve its expected performance goals.
  • Coinciding with the dismal financial results, R1 RCM also announced its CEO (Joseph Flanagan) was leaving his position.
  • If you invested in R1 RCM and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages R1 RCM Inc. (RCM) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Thursday, November 10, 2022
SAN, GLOBE, Key Performance Parameters, Bernard Joseph Flanagan, RCM, Fraud, Person, SEC, NASDAQ, News, Goal, Steve Berman (lawyer), Program, Mednax, Income, Real estate, Risk management

SAN FRANCISCO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM) investors who suffered significant losses to submit your losses now .
  • Management revealed that these customers had unique complexities, which resulted in R1 RCM taking longer to achieve its expected performance goals.
  • If you invested in R1 RCM and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

Nell Walker named to Product Compliance lead at Matrix Absence Management

Retrieved on: 
Monday, November 7, 2022
Consulting, Business, Professional Services, Insurance, Human Resources, MetLife, Senior, Assistant, Nell, Compliance, Cigna, Board, Associate, HR, Tokio Marine Nichido, Senior counsel, Disability, Chief compliance officer, Partnership, General counsel, Unum, Multimedia, Management, Insurance, Matrix, Mednax

Matrix Absence Management (Matrix), a leader in helping employers proactively manage employee absence and work force productivity, has named Nell Walker Vice President, Deputy General Counsel & Chief Compliance Officer.

Key Points: 
  • Matrix Absence Management (Matrix), a leader in helping employers proactively manage employee absence and work force productivity, has named Nell Walker Vice President, Deputy General Counsel & Chief Compliance Officer.
  • View the full release here: https://www.businesswire.com/news/home/20221107005967/en/
    Nell Walker, Vice President, Deputy General Counsel & Chief Compliance Officer, Matrix Absence Management (Photo: Business Wire)
    In her new role, Ms. Walker oversees an all-attorney Product Compliance team responsible for development, deployment and refinement of Matrixs service offerings.
  • Reporting to Matrix President Mark Marsters, she will also work closely with Reliance Standards Product Strategy team to build and refine integrated solutions and best practices related to absence, disability and productivity.
  • Matrix Absence Management and sister company Reliance Standard Life Insurance Company are members of the Tokio Marine Group.

USOSM Recruits Robert Manning as Vice President of Business Development

Retrieved on: 
Tuesday, September 13, 2022
Dialysis, University, Mednax, Baxter International, Nephrology, Harvard Law School, Private practice, Health, Growth, Partnership, Program, Program on Negotiation, Fresenius, Johnson & Johnson, Physician, Syracuse University, Neonatology, CEO, Society of Chest Pain Centers, Solution, Leadership, Anesthesiology, Fresenius Medical Care, Marketing, Radiology, Dentistry, Management, Manning

IRVING, Texas, Sept. 13, 2022 /PRNewswire-PRWeb/ -- U.S. Oral Surgery Management (USOSM) – a specialty management services company that exclusively serves premier oral and maxillofacial surgeons – has named healthcare industry veteran Robert Manning as a vice president of business development. In his new position, Manning will be responsible for the strategic growth and development of USOSM by seeking out new surgeon partners and ensuring a smooth transition during the partnership process.

Key Points: 
  • Oral Surgery Management (USOSM) has named healthcare industry veteran Robert Manning as a vice president of business development.
  • Oral Surgery Management ( USOSM) a specialty management services company that exclusively serves premier oral and maxillofacial surgeons has named healthcare industry veteran Robert Manning as a vice president of business development.
  • "We're excited to announce Robert Manning has joined USOSM as a vice president of business development," said Richard Hall, USOSM president and CEO.
  • Before that, Manning served as vice president of business development at Mednax Inc.

Mednax To Change Name to Pediatrix Medical Group, Inc. Effective July 1, 2022

Retrieved on: 
Tuesday, June 21, 2022
Women, General Health, Health, Children, Family, Baby, Maternity, Hospitals, Consumer, Neonatology, Education, Security (finance), Securities Exchange Act of 1934, COVID-19, Annual report, Anesthesiology, Mednax, Perception, Company, Blog, U.S. Securities and Exchange Commission, Forward-looking statement, Research, Private Securities Litigation Reform Act, LinkedIn, Medicare, Hospital, Securities Act of 1933, Critical care, New, Radiology, Physician, Affordable Care Act, MD, Investment, Obstetrics, Twitter, Care Act 2014, Legislation, Terminology, Instagram, NYSE, Pediatrics, Woman, Risk management, Medicaid, Facebook

Mednax, Inc. (NYSE: MD) today announced that it will change its corporate name to Pediatrix Medical Group, Inc., effective after the close of the market on July 1, 2022.

Key Points: 
  • Mednax, Inc. (NYSE: MD) today announced that it will change its corporate name to Pediatrix Medical Group, Inc., effective after the close of the market on July 1, 2022.
  • No action is necessary on the part of shareholders in connection with the name change; existing certificates that represent shares of Mednax, Inc. common stock will continue to represent shares of Pediatrix Medical Group, Inc. after the name change.
  • Mednax, Inc. is a national medical group comprised of the nations leading providers of physician services practicing under the Pediatrix brand.
  • To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook , Instagram , LinkedIn , Twitter and the Pediatrix blog .

Mednax Announces Leadership Appointments

Retrieved on: 
Wednesday, May 18, 2022
Nursing, Women, Children, Hospitals, Family, Managed Care, Health, Consumer, General Health, Linda, Physician, 19th (Western) Division, Education, Company, Kansas City metropolitan area, Mednax, Private Securities Litigation Reform Act, Region, U.S. Securities and Exchange Commission, Affordable Care Act, MD, Harbor–UCLA Medical Center, Leadership, Woman, Investment, Neonatology, Internal medicine, Health, DRS, Orange County, COVID-19, Chicago Medical School, Pickert, Legislation, Research, Medicare, Pediatrics, Securities Act of 1933, Securities Exchange Act of 1934, Critical care, Obstetrics, Time, Perception, Loma Linda University Medical Center, Instagram, Forward-looking statement, Terminology, Blog, University, Security (finance), LinkedIn, Twitter, Care Act 2014, Western University of Health Sciences, Anesthesiology, Radiology, NYSE, Annual report, Pharmaceutical industry, Medicine, Medicaid, Facebook

Mednax, Inc. (NYSE: MD) today announced two appointments to further strengthen its operating and clinical leadership.

Key Points: 
  • Mednax, Inc. (NYSE: MD) today announced two appointments to further strengthen its operating and clinical leadership.
  • Swift and Pickert have been with the Company for over a decade and have held expanding leadership roles over that time.
  • "Jim and Curt are invaluable physician leaders who have strengthened Pediatrix for many years, said Mark S. Ordan, Chief Executive Officer of Mednax.
  • Swift joined Mednax in 2009 and most recently served as the Companys Executive Vice President and Chief Development Officer.

Mednax Reports First Quarter Results

Retrieved on: 
Thursday, April 28, 2022
Other Health, Hospitals, Health, Nursing, Managed Care, Neonatology, Depreciation, Affordable Care Act, Legislation, Anesthesiology, Economy, U.S. Securities and Exchange Commission, EPS, LinkedIn, Radiology, Pediatrics, Securities Exchange Act of 1934, Webcast, Tax, Perception, Provisions of the Affordable Care Act, Twitter, Coronavirus, GAAP, Investment, Income, Education, Economic security, Critical care, Public expenditure, Mednax, Private Securities Litigation Reform Act, COVID-19, Forward-looking statement, ET, Obstetrics, Adjustment, Securities Act of 1933, Company, Medicare, Annual report, Woman, Security (finance), Note, Physician, Research, Terminology, Care Act 2014, Hand, SECURE Act of 2019, Blog, Debt-to-GDP ratio, Instagram, EBITDA, Health insurance, Video game, Pharmaceutical industry, Senior, Facebook, Medicaid

For the first quarter of 2022, transformational and restructuring related expenses totaled $1.4 million, compared to $4.9 million for the fourth quarter of 2021.

Key Points: 
  • For the first quarter of 2022, transformational and restructuring related expenses totaled $1.4 million, compared to $4.9 million for the fourth quarter of 2021.
  • Depreciation and amortization expense was $8.8 million for the first quarter of 2022 compared to $8.0 million for the first quarter of 2021.
  • For the first quarter of 2022, Mednax reported Adjusted EPS from continuing operations of $0.33, compared to $0.24 for the first quarter of 2021.
  • During the first quarter of 2022, Mednax used cash of $89.9 million to fund continuing operations, compared to a use of $98.9 million during the first quarter of 2021.

Mednax 2022 First Quarter Conference Call/Webcast Scheduled for Thursday, April 28, 2022

Retrieved on: 
Tuesday, April 19, 2022
Women, Practice Management, General Health, Health, Children, Baby, Maternity, Hospitals, Consumer, Affordable Care Act, Anesthesiology, Obstetrics, Woman, U.S. Securities and Exchange Commission, COVID-19, Security (finance), Twitter, Mednax, Care Act 2014, Research, Legislation, Annual report, MD, Private Securities Litigation Reform Act, Education, Terminology, Securities Act of 1933, Blog, LinkedIn, Securities Exchange Act of 1934, Radiology, Company, Webcast, Forward-looking statement, NYSE, Investment, Pediatrics, Critical care, Instagram, Physician, Neonatology, Medicare, Perception, Risk management, Facebook, Medicaid

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, April 28, 2022 at 9:00 a.m.

Key Points: 
  • Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, April 28, 2022 at 9:00 a.m.
  • ET, to discuss results from operations for the quarter ended March 31, 2022.
  • A detailed press release will be issued the morning of April 28, 2022 before the securities markets open.
  • Mednax, Inc. is a national medical group comprised of the nations leading providers of physician services practicing under the Pediatrix brand.

Mednax-Affiliated Practices to Adopt Pediatrix® Brand

Retrieved on: 
Wednesday, March 2, 2022
Nursing, Women, Children, Hospitals, Baby, Maternity, Managed Care, Health, Consumer, General Health, Ordan Petlevski, Blog, Patient, Mednax, Investment, Critical care, Research, Name, Woman, Twitter, Neonatology, Safety, Instagram, LinkedIn, Awareness, NYSE, Multimedia, Summit Medical Group, Obstetrics, Health, Medicine, Education, MD, Physician, Pharmaceutical industry, Jewellery, Facebook

Mednax, Inc. (NYSE: MD) today announced that its affiliated practices will adopt the Pediatrix Medical Group brand nationwide, reflecting the groups role as the nations leading provider of highly specialized health care for women, babies and children.

Key Points: 
  • Mednax, Inc. (NYSE: MD) today announced that its affiliated practices will adopt the Pediatrix Medical Group brand nationwide, reflecting the groups role as the nations leading provider of highly specialized health care for women, babies and children.
  • Aligning our affiliated practices with the Pediatrix brand will enable our patients to identify the broad range of care we offer in these unique fields of medicine, including among underserved communities, added Curt Pickert, M.D., executive vice president of Clinical Services.
  • Mednax, Inc. is a national medical group comprised of the nations leading providers of physician services practicing under the Pediatrix brand.
  • To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook , Instagram , LinkedIn , Twitter and the Pediatrix blog .